Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for global professionals · Tuesday, April 23, 2024 · 705,813,030 Articles · 3+ Million Readers

Ethicon Hit with TVT-O Lawsuit in East Texas by Martin Baughman, PLLC

Dr. Greg Vigna

Dr. Greg Vigna

Dr. Greg Vigna, national pharmaceutical injury attorney and practicing physician, comments on the vaginal mesh litigation by his law firm.

The risks of the transobturator sling far outweigh the perceived benefit given there are much safer designs and procedures available for the treatment of stress urinary incontinence.”
— Dr. Greg Vigna

SANTA BARBARA, CALIFORNIA, UNITED STATES, July 30, 2021 /EINPresswire.com/ -- “The Ethicon TVT-O continues to cause serious injuries acutely after implantation or become symptomatic years”…Greg Vigna, MD, JD

In July 2021, Ethicon, Inc. was hit with a lawsuit filed by a woman who sustained grievous ‘latent’ injuries caused by the implantation of the TVT-O device in June of 2008, a polypropylene sling, used for the treatment of stress urinary incontinence in the Eastern District of Texas, Texarkana Division, (No. 5:21-cv-00092).

Transobturator (TOT) slings and single-incision slings that insert into the obturator internus muscle are known to chronic pain syndromes that may occur acutely after shortly after implant, or ‘latent injuries’ that become symptomatic months to years later caused by perpetual inflammation and scarification.

Greg Vigna, MD, JD, national pharmaceutical injury attorney, practicing physician, and Certified Life Care Planner comments on the vaginal mesh litigation by his law firm:

“Boston Scientific, Coloplast, and Ethicon, as to this day they still have not warned physicians of the risk of pudendal and obturator neuralgia from a properly placed TOT device that was described by AUGS in 2020 as ‘extrapelvic pain’ in the AUGS-IUGA Joint Position Statement on the Management of Mesh-Related Complications for the FPMRS Specialist. The risks of the transobturator sling far outweigh the perceived benefit given there are much safer designs and procedures available for the treatment of stress urinary incontinence. My firm will be litigating these cases for years to come or until the last polypropylene transvaginal mesh device is surgically removed.”

The Plaintiff is represented by Ben C. Martin and Laura Baughman of Martin Baughman, PLLC, and Greg Vigna, MD, JD. Ben Martin and Laura Baughman are national pharmaceutical injury attorneys in Dallas, Texas. Dr. Vigna is a California and Washington DC lawyer who focuses on catastrophic injuries and the neurological injuries caused by transvaginal mesh devices including pudendal neuralgia, obturator neuralgia, ilioinguinal neuralgia, and Complex Regional Pain Syndrome.

The Vigna Law Group targets the below transobturator (TOT) slings and mini-slings that cause pudendal and obturator neuralgia:

Ethicon: TVT-O, Abbrevo
Boston Scientific: Obtryx, Solyx
Coloplast: Aris, Altis

The Vigna Law Group targets the below retropubic slings that cause ilioinguinal neuralgia, pudendal neuralgia, and Complex Regional Pain Syndrome:

Ethicon: TVT, TVT-Exact
Boston Scientific: Advantage Fit, Lynx
Coloplast: Supris

Groin and Pelvic pain: Read about TOT complications including obturator and pudendal neuralgia and the treatments of obturator and pudendal neuralgia visit: https://vignalawgroup.com/ebooks/pelvic-mesh-pain/#page=59

Download and READ our Vaginal Mesh Pain eBook.
For articles, video resources, and information visit the Pudendal Neuralgia Educational Portal or https://tvm.lifecare123.com/.
Click here for information regarding sling-related complications.

Greg Vigna, MD, JD
Vigna Law Group
1155 Coast Village Rd., Suite 3, Santa Barbara, CA
1-800-761-9206

Greg Vigna, M.D., J.D., Certified Life Care Planner
Academic Physician Life Care Planning
+1 800-761-9206
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn

Powered by EIN Presswire


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release